RI-MUHC innovative clinical trial assesses hydroxychloroquine for prevention and treatment of COVID-19
Initially restricted to health care workers in Quebec, the clinical study is now open to all eligible adults
COVID-19 coronavirus and tuberculosis: We need a damage control plan
Dr. Madhukar Pai explains why TB services might be one of the biggest casualties of the pandemic
RI-MUHC researcher on Innovation Panel at the U.S. National Academy of Sciences
Dr. Nitika Pant Pai speaks out on global microbial threats
Vitamin E effective, safe for fatty liver in HIV patients
RI-MUHC researcher Dr. Giada Sebastiani is lead author of study published in the journal AIDS
Overcoming the greatest obstacle to curing HIV
RI-MUHC researcher participated in the groundbreaking study published in Nature
The Pfizer Investigator Training Program comes to the RI-MUHC!
Clinical research educational training program benefits researchers, staff and students at the inaugural event
Reaching beyond the hallowed halls of academe
“With science under attack, scientists have little choice but to step into the limelight and fight for what matters most” – Dr. Madhukar Pai
Meeting the global health challenge of worms that cause disease
Theresa Gyorkos has dedicated her career to understanding and reducing the harms caused by parasitic worm infection
The Arthritis Society honours scleroderma research by former RI-MUHC research trainee
Dr. Sabrina Hoa’s publication listed in “Top 10 Research Advances of 2019”
In Memoriam: Ernest Seidman, MD
It is with great sadness that we inform you of the sudden passing of Dr. Ernest Seidman